AN AUTHORITATIVE RESOURCE FOR EVERYTHING ABOUT CANCER
Abdullah Mohammad Khan, MBBS
an associate professor of medicine
Abdullah Mohammad Khan, MBBS, is an associate professor of medicine at The Ohio State University Comprehensive Cancer Center (OSUCCC-James), where he specializes in multiple myeloma and related plasma cell disorders. His clinical practice spans the full disease spectrum, from monoclonal gammopathy of undetermined significance through smoldering and active multiple myeloma, with particular focus on relapsed and refractory disease and high-risk features. Research interests center on the development of novel anti-myeloma therapies through clinical trial participation and translational collaboration to better understand disease biology. Training included a hematology and oncology fellowship at the University of Florida.
Published Articles (1)
September 21, 2026
Indefinite lenalidomide maintenance after transplant has been standard practice in multiple myeloma for years, largely on the strength of older trials that never directly tested whether stopping was safe.